Loading
Latest filing published 08 Apr 2025 for Humacyte, Inc., €7,049.
Not enough history yet: 0 closed purchases, at least 2 are needed.
Charles Bruce Green appears in our data through filings on Humacyte, Inc. shares, published by SEC (Form 4). We count 4 filings; the first trade dates from 17 May 2024 and the latest from 8 April 2025.
No open-market sale appears; the market trades are 1 purchase worth €7,049. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Besides market trades, the filings include 3 option exercises. In 2025 alone, the filings show 1 purchase and no sales.
The latest filing, published on 8 April 2025, reports an open-market purchase of €7,049 in Humacyte, Inc. Typically, a trade is published a median of 3 days after it takes place. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations